公开(公告)号：EP3394825B1

公开(公告)日：2024-05-22

申请号：EP16876856.2

申请日：2016-12-16

IPC分类号： G16H50/70 ,  G16H50/20 ,  A61B5/00 ,  G16H20/70 ,  A61B5/16

CPC分类号： A61B5/7267 ,  A61B5/0022 ,  A61B5/168 ,  A61B5/4088 ,  A61B5/4833 ,  A61B5/486 ,  G16H50/70 ,  G16H50/20 ,  G16H20/70 ,  A61B5/163 ,  G16H10/20

公开(公告)号：EP3580700A1

公开(公告)日：2019-12-18

申请号：EP18750938.5

申请日：2018-02-08

申请人： Cognoa, Inc.

发明人： VAUGHAN, Brent

IPC分类号： G06N5/04

公开(公告)号：EP4437962A2

公开(公告)日：2024-10-02

申请号：EP24176472.9

申请日：2016-12-16

申请人： Cognoa, Inc.

发明人： ABBAS, Abdelhalim ,  VAUGHAN, Brent

IPC分类号： A61B5/16

CPC分类号： A61B5/7267 ,  A61B5/0022 ,  A61B5/168 ,  A61B5/4088 ,  A61B5/4833 ,  A61B5/486 ,  G16H50/70 ,  G16H50/20 ,  G16H20/70 ,  A61B5/163 ,  G16H10/20

摘要： The methods and apparatus disclosed herein provide digital diagnostics and digital therapeutics to patients. The digital personalized medicine system uses digital data to assess or diagnose symptoms of a patient, and feedback from the patient response to treatment is considered to update the personalized therapeutic interventions. The methods and apparatus disclosed herein can also diagnose and treat cognitive function of a subject, with fewer questions, decreased amounts of time, and determine a plurality of behavioral, neurological or mental health disorders, and provide clinically acceptable sensitivity and specificity in the diagnosis and treatment.

公开(公告)号：EP3335126A1

公开(公告)日：2018-06-20

申请号：EP16835913.1

申请日：2016-08-11

申请人： Cognoa, Inc.

发明人： VAUGHAN, Brent ,  LAJONCHERE, Clara ,  WALL, Dennis ,  HACK, Jay ,  HACK, Charlie

IPC分类号： G06F15/18

CPC分类号： A61B5/16 ,  A61B5/00 ,  A61B5/168 ,  A61B5/7275 ,  G06F19/00 ,  G16H10/20 ,  G16H50/20 ,  G16H50/70

摘要： The methods and apparatus disclosed herein can diagnose or identify a subject as at risk of having one or more developmental disorders with fewer questions, decreased amounts of time, and determine a plurality of developmental disorders, and provide clinically acceptable sensitivity and specificity in a clinical environment. The methods and apparatus disclosed herein can be configured to diagnose or determine the subject as at risk of a developmental disorder among a plurality of developmental disorders, and decreasing the number of questions presented can be particularly helpful where a subject presents with a plurality of possible developmental disorders. A processor can be configured with instructions to identify a most predictive next question, such that a person can be diagnosed or identified as at risk with fewer questions.

公开(公告)号：EP3539033B1

公开(公告)日：2024-10-02

申请号：EP17869145.7

申请日：2017-11-14

IPC分类号： G16H20/10 ,  G16H50/20 ,  G16H20/70 ,  G16H50/70

CPC分类号： G16H20/70 ,  G16H50/70 ,  G16H50/20 ,  G16H20/10

公开(公告)号：EP3394825A1

公开(公告)日：2018-10-31

申请号：EP16876856.2

申请日：2016-12-16

申请人： Cognoa, Inc.

发明人： ABBAS, Abdelhalim ,  VAUGHAN, Brent

IPC分类号： G06Q50/24 ,  G06Q50/22 ,  A61B5/00 ,  G06F15/18 ,  G06F17/30

CPC分类号： G06F19/30 ,  A61B5/0022 ,  A61B5/168 ,  A61B5/4088 ,  A61B5/4833 ,  A61B5/486 ,  A61B5/7267 ,  G06F19/00

摘要： The methods and apparatus disclosed herein provide digital diagnostics and digital therapeutics to patients. The digital personalized medicine system uses digital data to assess or diagnose symptoms of a patient, and feedback from the patient response to treatment is considered to update the personalized therapeutic interventions. The methods and apparatus disclosed herein can also diagnose and treat cognitive function of a subject, with fewer questions, decreased amounts of time, and determine a plurality of behavioral, neurological or mental health disorders, and provide clinically acceptable sensitivity and specificity in the diagnosis and treatment.